Completion of the Updated Caprini Risk Assessment Model (2013 Version)

MaryAnne Cronin, Nancy Dengler, Eugene S Krauss, Ayal Segal, Nicole Wei, Madison Daly, Frank Mota, Joseph A Caprini, MaryAnne Cronin, Nancy Dengler, Eugene S Krauss, Ayal Segal, Nicole Wei, Madison Daly, Frank Mota, Joseph A Caprini

Abstract

The Caprini risk assessment model (RAM) has been validated in over 250 000 patients in more than 100 clinical trials worldwide. Ultimately, appropriate treatment options are dependent on precise completion of the Caprini RAM. As the numerical score increases, the clinical venous thromboembolism rate rises exponentially in every patient group where it has been properly tested. The 2013 Caprini RAM was completed by specially trained medical students via review of the presurgical assessment history, medical clearances, and medical consults. The Caprini RAM was completed for every participant both preoperatively and predischarge to ensure that any changes in the patient's postoperative course were captured by the tool. This process led to the development of completion guidelines to ensure consistency and accuracy of scoring. The 2013 Caprini scoring system provides a consistent, thorough, and efficacious method for risk stratification and selection of prophylaxis for the prevention of venous thrombosis.

Keywords: Caprini risk assessment; deep vein thrombosis; pulmonary embolism; risk stratification; thromboprophylaxis.

Conflict of interest statement

Declaration of Conflicting Interests: The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Caprini Risk Assessment Model (version 2013).
Figure 2.
Figure 2.
Patient-friendly tool (Caprini RAM version 2013) - side 1. Completed by the patient -side 2. Completed by the Healthcare Provider.
Figure 2.
Figure 2.
Patient-friendly tool (Caprini RAM version 2013) - side 1. Completed by the patient -side 2. Completed by the Healthcare Provider.

References

    1. Maynard G, Stein J. Designing and implementing effective venous thromboembolism prevention protocols: lessons from collaborative efforts. J Thromb Thrombolysis. 2010;29(2):159–166. doi:10.1007%2Fs11239-009-0405-4.
    1. Mahan CE, Spyropoulos AC. Venous thromboembolism prevention: a systematic review of methods to improve prophylaxis and decrease events in the hospitalized patient. Hosp Pract. 2010;38(1):97–108. doi:10.3810/hp.2010.02.284.
    1. Becattini C, Agnelli G. Treatment of venous thromboembolism with new anticoagulant agents. J Am Coll Cardiol. 2016;67(16):1941–1955. doi:10.1016/j.jacc.2016.01.072.
    1. Wakefield TW, McLafferty RB, Lohr JM, et al. Call to action to prevent venous thromboembolism. J Vasc Surg. 2009;49(6):1620–1623. doi:10.1016/j.jvs.2009.01.058.
    1. Beckman MG, Hooper WC, Critchley SE, Ortel TL. Venous thromboembolism a public health concern. Am J Prev Med. 2010;38(4S):S495–S501. doi:10.1016/j.amepre.2009.12.017.
    1. Geerts WH, Bergqvist D, Pineo GF, et al. Prevention of venous thromboembolism. American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest. 2008;133(suppl 6):381S–453S. doi:10.1378/chest.08-0656.
    1. Barbar S, Noventa F, Rossetto V, et al. A risk assessment model for the identification of hospitalized medical patients at risk for venous thromboembolism: the Padua Prediction Score. J Thromb Haemost. 2010;8(11):2450–2457. doi:10.1111/j.1538-7836.2010.04044.x.
    1. Spyropoulos AC, Anderson FA, FitzGerald G, et al. Predictive and associative models to identify hospitalized medication patients at risk for VTE. Chest. 2011;140(3);706–714. doi:10.1378/chest.10-1944.
    1. Gould MK, Garcia DA, Wren SM, et al. Prevention of VTE in nonorthopedic surgical patients. antithrombotic therapy and prevention of thrombosis, 9th edition: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012;141(2 suppl):e227S–e277S. doi:10.1378/chest.11-2297.
    1. Laryea J, Champagne B. Venous thromboembolism prophylaxis. Clin Colon Rectal Surg. 2013;26(3):153–159. doi:10.1055/s-0033-1351130.
    1. Caprini JA, Arcelus JI, Hasty JH, Tamhane AC, Fabrega F. Clinical Assessment of venous thromboembolic risk in surgical patients. Semin Thromb Hemost. 1991;17(suppl 3):304–312. doi:10.1136/bmj.g5334.
    1. Luksameearunothai K, Sa-Ngasoongsong P, Kulachote N, et al. Usefulness of clinical predictors for preoperative screening of deep vein thrombosis in hip fractures. BMC Musculoskelet Disord. 2017;18(1):208 doi:10.1186/s12891-017-1582-5.
    1. Hatef D, Kenkel JM, Nguyen MQ, et al. Thromboembolic risk assessment and the efficacy of enoxaparin prophylaxis in excision body contouring surgery. Plast Reconstr Surg. 2008;122(1):269–279. doi:10.1097/PRS.0b013e3181773d4a.
    1. Seruya M, Venturi M. Efficacy and safety of venous thromboembolism prophylaxis in highest risk plastic surgery patients. Plast Reconstr Surg. 2008;122(6):1701–1708. doi:10.1097/PRS.0b013e31818dbffd.
    1. Bahl V, Hu HM, Henke PK, Wakefield TW, Campbell DA, Jr, Caprini JA. A validation study of a retrospective venous thromboembolism risk scoring method. Ann Surg. 2010;251(2):344–350. doi:10.1097/SLA.0b013e3181b7fca6.
    1. Pannucci CJ, Bailey SH, Dreszer G, et al. Validation of the Caprini risk assessment model in plastic and reconstructive surgery patients. J Am Coll Surg. 2011;212(1):105–112. doi:10.1016/j.jamcollsurg.2010.08.018.
    1. Shuman AG, Hu HM, Pannucci CJ, Jackson CR, Bradford CR, Bahl V. Stratifying the risk of venous thromboembolism in otolaryngology. Otolaryngol Head Neck Surg. 2012;146(5):719–724. doi:10.1177/0194599811434383.
    1. Stroud W, Whitworth JM, Miklic M, et al. Validation of a venous thromboembolism risk assessment model in gynecologic oncology. Gynecol Oncol. 2014;134(1):160–163. doi:10.1016/j.ygyno.2014.04.051.
    1. Obi AT, Pannucci CJ, Nackashi A, et al. Validation of the Caprini venous thromboembolism risk assessment model in critically Ill surgical patients. JAMA Surg. 2015;150(10):941–948. doi:10.1001/jamasurg.2015.1841.
    1. Lobastov K, Barinov V, Schastlivtsev I, Laberko L, Rodoman G, Boyarintsev V. Validation of the Caprini risk assessment model for venous thromboembolism in high-risk surgical patients in the background of standard prophylaxis. J Vasc Surg Venous Lymphat Disord. 2016;4(2):153–160. doi:10.1016/j.jvsv.2015.09.004.
    1. Krasnow R, Gelpi-Hammerschmidt F, Preston M, et al. Validation of the Caprini risk assessment model in radical cystectomy patients. J Urology. 2016;95(4 suppl):e823–e824. doi:10.1016/j.juro.2016.02.937.
    1. Saragas NP, Ferrao PN, Jacobson BF, Saragas E, Strydom A. The benefit of pharmacological venous thromboprophylaxis in foot and ankle surgery. S Afr Med J. 2017;107(4):327–330. doi:10.1016/j.fas.2013.11.002.
    1. Krauss ES, Segal A, Cronin M, Dengler N, Lesser ML, Ahn S, Caprini JA. Implementation and Validation of the 2013 Caprini Score for Risk Stratification of Arthroplasty Patients in the Prevention of Venous Thrombosis. Clinical and Applied Thrombosis/Hemostasis; 2019.
    1. Pannucci CJ, Swistun L, MacDonald JK, Kenke PK, Brooke BS. Individualized venous thromboembolism risk stratification using the 2005 Caprini score to identify the benefits and harms of chemoprophylaxis in surgical patients. Ann Surg. 2017;265(6):1094–1103. doi:10.1097/SLA.0000000000002126.
    1. Illinois Medical Society. .
    1. Rocha AT, de Vasconcellos AG, da Luz Neto ER, Araújo DM, Alves ES, Lopes AA. Risk of venous thromboembolism and efficacy of thromboprophylaxis in hospitalized obese medical patients and in obese patients undergoing bariatric surgery. Obes Surg. 2006;16(12):1645–1655. doi:10.1381/096089206779319383.
    1. Martin K, Beyer-Westendorf J, Davidson BL, Huisman MV, Sandset PM, Moll S. Use of the direct oral anticoagulants in obese patients: guidance from the SSC of the ISTH. J Thromb Haemost. 2016;14(6):1308–1311. doi:10.1111/jth.13323.
    1. Sweetland S, Parkin L, Balkwill A, et al. Smoking, surgery and venous thromboembolism risk in women. United Kingdom cohort study. Circulation. 2013;127(12):1276–1282. doi:10.1161/CIRCULATIONAHA.113.001428.
    1. Enga KF, Brækkan SK, Hansen-Krone IJ, le Cessie S, Rosendaal FR, Hansen JB. Cigarette smoking and the risk of venous thromboembolism: the Tromsø Study. J Thromb Haemost. 2012;10(10):2068–2074. doi:10.1111/j.1538-7836.2012.04880.x.
    1. Chung W, Lin C, Kao C. Diabetes increases the risk of deep-vein thrombosis and pulmonary embolism. A population-based cohort study. Thromb Haemost. 2015;114(4):812–818. doi:10.1160/TH14-10-0868.
    1. van Schouwenburg IM, Mahmoodi BK, Veeger NJGM, et al. Insulin resistance and risk of venous thromboembolism: results of a population-based cohort study. J Thromb Haemost. 2012;10(6):1012–1018. doi:10.1111/j.1538-7836.2012.04707.x.
    1. Haddad TC, Greeno EW. Chemotherapy-induced thrombosis. Thromb Res. 2006;118(5):555–568. doi:10.1016/j.thromres.2005.10.015.
    1. Khorana AA, Dalal M, Lin J, Connolly GC. Incidence and predictors of venous thromboembolism (VTE) among ambulatory high-risk cancer patients undergoing chemotherapy in the United States. Cancer. 2013;119(3):648–655. doi:10.1002/cncr.27772.
    1. Spinella PC, Carroll CL, Staff I, et al. Duration of red blood cell storage is associated with increased incidence of deep vein thrombosis and in hospital mortality in patients with traumatic injuries. Crit Care. 2009;13(5):R151 doi:10.1186/cc8050.
    1. Vasan SK, Rostgaard K, Majeed A, et al. ABO blood group and risk of thromboembolic and arterial disease. A study of 1.5 million blood donors. Circulation. 2016;133(15):1449–1457. doi:10.1161/CIRCULATIONAHA.115.017563.
    1. Borow M, Goldson H. Postoperative venous thrombosis. Evaluation of five methods of treatment. Am J Surg. 1981;141(2):245–251.
    1. Pannucci CJ, Shanks A, Moote MJ, Bahl V, Cederna PS. Identifying patients at high risk for venous thromboembolism requiring treatment after outpatient surgery. Ann Surg. 2012;255(6):1093–1099. doi:10.1097/SLA.0b013e3182519ccf.
    1. Fuentes HE, Paz LH, Al-Ogaili A, et al. Validation of a patient-completed Caprini risk score for venous thromboembolism risk assessment. TH Open. 2017;1(2):e106–e112. doi:10.1055/s-0037-1607339.
    1. Zöller B, Ohlsson H, Sundquist J, Sundquist K. Familial risk of venous thromboembolia in first-, second- and third-degree relatives: a nationwide family study in Sweden. Thromb Haemost. 2013;109(3):458–463. doi:10.1160/TH12-10-0743.
    1. Bezemer ID, van der Meer FJ, Eikenbook JC, Rosendall FR, Doggen CJ. The value of family history as a risk indicator for venous thrombosis. Arch Intern Med. 2009;169(6):610–615. doi:10.1001/archinternmed.2008.589.
    1. Pannucci CJ, Fleming KI. Comparison of face-to-face interaction and the electronic medical record for venous thromboembolism risk stratification using the 2005 Caprini score. J Vasc Surg Venous Lymphat Disord. 2018;6(3):304–311. doi:10.1016/j.jvsv.2017.10.016.
    1. White RH, Henderson MC. Risk factors for venous thromboembolism after total hip and knee replacement surgery. Curr Opin Pulm Med. 2002;8(5):375–371.
    1. White RH, Gettner S, Newman JM, Trauner KB, Romano PS. Predictors of rehospitalization for symptomatic venous thromboembolism after total hip arthroplasty. N Engl J Med. 2000;343(24):1758–1764. doi:10.1056/NEJM200012143432403.
    1. Abdollahi M, Cushman M, Rosendaal FR. Obesity: risk of venous thrombosis and the interaction with coagulation factor levels and oral contraceptive use. Thromb Haemost. 2003;89(3):493–498.
    1. Amin AN, Girard F, Samama MM. Does ambulation modify venous thromboembolism risk in acutely ill medical patients? Thromb Haemost. 2010;104(5):955–961. doi:10.1160/TH10-04-0236.
    1. Greer IA. Thrombophilia: implications for pregnancy outcome. Thromb Res. 2003;109(2-3):73–81. doi:10.1016/S0049-3848(03)00095-1.
    1. Roach RE, Lijfering WM, van Hylckama Vlieg A, et al. The risk of venous thrombosis in individuals with a history of superficial vein thrombosis and acquired venous thrombotic risk factors. Blood. 2013;122(26):4264–4269. doi:10.1182/blood-2013-07-518159.
    1. Caprini JA. Risk assessment as a guide for the prevention of the many faces of venous thromboembolism. Am J Surg. 2010;199(1 suppl):S3–10. doi:10.1016/j.amjsurg.2009.10.006.
    1. Shen YM, Frenkel EP. Thrombosis and a hypercoagulable state in HIV-infected patients. Clin Appl Thromb Hemost. 2004;10(3):277–280. doi:10.1177/107602960401000311.

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren